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ABSTRACT
Human embryonic stem (hES) cells can generate cells
expressing p63, K14, and involucrin, which have been pro-
posed to be keratinocytes. Although these hES-derived,
keratinocyte-like (hESderK) cells form epithelioid colonies
when cultured in a ﬁbroblast feeder system optimal for nor-
mal tissue-derived keratinocytes, they have a very short
replicative lifespan unless engineered to express HPV16
E6E7. We report here that hESderK cells undergo senescence
associated with p16
INK4A expression, unrelated to telomere
status. Transduction to express bmi1, a repressor of the
p16
INK4A/p14
ARF locus, conferred upon hESderK cells and
keratinocytes a substantially extended lifespan. When exposed
to transforming growth factor beta or to an incompletely
processed form of Laminin-332, three lifespan-extended or
immortalized hESderK lines that we studied became direc-
tionally hypermotile, a wound healing and invasion response
previously characterized in keratinocytes. In organotypic cul-
ture, hESderK cells stratiﬁed and expressed involucrin and
K10, as do epidermal keratinocytes in vivo. However, their
growth requirements were less stringent than keratinocytes.
We then extended the comparison to endoderm-derived,
p63
1/K14
1 urothelial and tracheobronchial epithelial cells.
Primary and immortalized lines of these cell types had growth
requirements and hypermotility responses similar to keratino-
cytes and bmi1 expression facilitated their immortalization by
engineering to express the catalytic subunit of telomerase
(TERT). In organotypic culture, they stratiﬁed and exhibited
squamous metaplasia, expressing involucrin and K10. Thus,
hESderK cells proved to be distinct from all three normal
p63
1 cell types tested. These results indicate that hESderK
cells cannot be identiﬁed conclusively as keratinocytes or even
as ectodermal cells, but may represent an incomplete form of,
or deviation from, normal p63
1 lineage development. STEM
CELLS 2009;27:1388–1399
Disclosure of potential conﬂicts of interest is found at the end of this article.
INTRODUCTION
Since their initial cultivation and characterization [1, 2],
human embryonic stem (hES) cell lines have attracted interest
for their potential to produce functional somatic cells for cell
replacement therapy and to elucidate mechanisms of lineage
development [3]. However, few reports have described deriva-
tion from hES cells of even modestly proliferative, partially
puriﬁed populations displaying features of a speciﬁc somatic
cell type [4–7]. A major obstacle to evaluating normality,
quality, and suitability of such cells for human use is the ab-
sence of optimized culture media for many normal cell types,
necessary to evaluate proliferative and differentiation potential
of hES-derived cells against proper standards. Some cell
types, such as epidermal keratinocytes, can be expanded
greatly in culture from small biopsies from the intended recip-
ient, obviating the necessity to derive them from hES cells for
therapy. Yet, this substantial proliferative potential of post-
natal epidermal keratinocytes in culture and their ability to
undergo histogenesis in experimental transplant [8–10] and
organotypic culture [11–13] models and to re-establish
normal, functioning, and permanent tissue in autologous trans-
plants [14–16] provides a strong rationale for generating
keratinocytes from hES cells to obtain proof-of-principal for
hES-derived cell therapy.
The keratinocyte is the cell type that forms stratiﬁed
squamous epithelia, including the epidermis and corneal,
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These epithelia have distinctive cytokeratin expression patterns
and suprabasal architecture [17–19] and are formed by intrinsi-
cally specialized keratinocyte ‘‘subtypes.’’ These are pro-
grammed during development to preferentially undergo a site-
speciﬁc pattern of suprabasal differentiation and they maintain
their identity during serial culture [9, 10, 13]. Human keratino-
cytes grow rapidly and for a long, ﬁnite replicative lifespan (25
to  80 population doublings [PD], varying by tissue site and
donor) in optimized media [10, 20–22].
As for all normal somatic cell types, keratinocyte replicative
potential in culture is subject to limitation by a p53-/
p21
cip1-dependent senescence mechanism triggered by progres-
sive telomere erosion. However, keratinocyte lifespan typically
is determined by the timing of derepression of the CDKN2A
gene, encoding the cell cycle inhibitors p16
INK4A and p14
ARF.
This event, referred to as ‘‘p16 senescence,’’ occurs abruptly and
with ever increasing frequency during serial passage [20, 23], in-
dependent of telomere status. Keratinocytes must undergo muta-
tions or be engineered to evade this mechanism to become
immortalized by telomerase catalytic subunit (TERT) expression
[20, 23–25]. p16 expression also limits replicative potential of
mammary epithelial and urothelial cells and acts as a barrier to
their immortalization [26, 27]. In vivo, p16 plays no role in nor-
mal epithelial tissue homeostasis or development [28, 29] but is
expressed speciﬁcally by cells that become migratory at the
edges of wounds or that are poised to begin invasion in prema-
lignant lesions [30, 31]. A hypermotility response associated
with growth arrest can be elicited in normal keratinocytes in an
experimental culture model of this mechanism [30].
Following identiﬁcation of cells expressing the corniﬁed
envelope protein involucrin and K10 in outgrowth cultures of
embryoid bodies formed by murine ES cells [32], several labs
identiﬁed p63
þ/K14
þ epithelial cells with the potential to
express involucrin arising from hES cells [33–37]. The tran-
scription factor p63 and the cytokeratin protein K14 were ﬁrst
identiﬁed as markers and studied most intensively for their
roles in epidermal development and function, but they are
expressed by a variety of epithelial tissues and cell types [17–
19, 38–42]. Occasional appearance of involucrin
þ cells in
hES-derived cultures led to a preliminary conclusion that
these cells are keratinocytes, and we refer to them here as
‘‘hES-derived, keratinocyte-like (hESderK)’’ cells. hESderK
cells form colonies in the feeder/FAD system [33–37] but
their replicative potential is extremely limited (<15 PD), pre-
venting their analysis. In a recent collaborative study [35],
after ﬁnding that they were not immortalized by TERT trans-
duction, we immortalized hESderK cells with HPV16 E6E7, a
method ﬁrst used to immortalize normal keratinocytes [43–
46]. hESderK/E6E7 cells differed morphologically from nor-
mal somatic keratinocytes and underwent very limited stratiﬁ-
cation and involucrin expression [35] and we considered the
possibility that these differences resulted from expression of
the E6E7 oncoproteins.
Here, we report a comprehensive analysis of three hES-
derK lines for morphology, marker expression, growth
requirements, motility, and histogenic potential, comparing
them with normal primary and experimentally immortalized
epidermal keratinocytes and two other p63
þ/K14
þ epithelial
cell types—urothelial and tracheobronchial epithelial cells.
We evaluated effects on cell behavior of expressing bmi1, a
polycomb protein that maintains repression of the p16
INK4A/
p14
ARF locus [47–49], to confer extended lifespan. We ﬁnd
that hESderK cells share many features with keratinocytes
and other p63
þ cell types but that they clearly differ from all
of them, suggesting that hESderK cells are an incomplete or
abnormal form of p63
þ lineage development.
MATERIALS AND METHODS
Cell Lines and Culture Media
Cell lines studied are listed in Table 1. Strain N, J4Ep, HBL-10U,
LP9, R2F, and TrBEp-1 are primary cell lines (also known as cell
strains), that is, cells cultured from normal tissues and serially
propagable for a ﬁnite replicative lifespan, during which they
remain genetically and functionally normal. The p63
þ/K14
þ ‘‘hES-
derK’’ cell population [34] derived from a teratoma formed by H9
hES cells and the hESderK/E6E7 cl2 (nod3-c2) line [35] derived
from these hESderK cells were reported previously. hESderK/
E6E7 clK was clonally isolated from the same mass hESderK/
E6E7 population from which cl2 had been isolated. hESderK/bmi1
is a bmi1/puro-transduced cell line derived from the same original
hESderK cell population [34] that had been used to generate the
E6E7 clones.
For some experiments, cells were cultured using the feeder/
FAD system [20, 21, 52]: cocultivation with c-irradiated 3T3J2
cells in FAD medium: Dulbecco’s modiﬁed Eagle’s medium
(DMEM)/F12 (1:1 v/v) (Gibco, Grand Island, NY, http://www.
invitrogen.com/Invitrogen, Carlsbad, CA, http://www.invitrogen.
com) þ5% iron-supplemented bovine calf serum (HyClone,
Table 1. Cell lines studied
Cell lines Cell type References
Strain N Newborn foreskin epidermal keratinocyte 20
N/E6E7 Newborn foreskin epidermal keratinocyte 30
N/bmi1 Newborn foreskin epidermal keratinocyte
N/bmi1/TERT Newborn foreskin epidermal keratinocyte
J4Ep  20 wk fetal epidermal keratinocyte
hESderK/E6E7 clone 2 H9 hES-derived, p63þK14þ epithelial cell 35
hESderK/E6E7 clone K H9 hES-derived, p63þK14þ epithelial cell
hESderK/bmi1 H9 hES-derived, p63þK14þ epithelial cell
hESderK/bmi1/E6E7 H9 hES-derived, p63þK14þ epithelial cell
HBl-10U Urothelial cell 50, 51
HBl-10U/E6E7 Urothelial cell
HBl-10U/bmi1/TERT Urothelial cell
LP9 Adult peritoneal mesothelial cell 19, 20
R2F Newborn foreskin ﬁbroblast 23
TrBEp-1 Tracheobronchial epithelial cell
TrBEp-1/bmi1/TERT Tracheobronchial epithelial cell
Dabelsteen, Hercule, Barron et al. 1389
www.StemCells.comLogan, UT, http://www.hyclone.com), 10 ng/ml epidermal growth
factor (EGF), 0.4 lg/ml hydrocortisone, 1.8   10
 4 M adenine,
10
 10 M cholera toxin, 5 lg/ml insulin, 2   10
 11 M triiodothyr-
onine, and penicillin/streptomycin (pen/strep). For most experi-
ments, keratinocytes and urothelial cells were cultured in
keratinocyte serum-free medium (K-sfm) (Gibco) supplemented
as described [20] with 25 lg/ml bovine pituitary extract (BPE),
0.2 ng/ml EGF, an additional 0.3 mM CaCl2 to bring total [Ca
2þ]
to 0.4 mM, and pen/strep. To generate healthy high-density cul-
tures, cells were grown to  40% conﬂuence in K-sfm, then refed
daily with a 1:1 (vol:vol) mixture of K-sfm and ‘‘DF-K medium,’’
the latter consisting of a 1:1 (vol:vol) mixture of calcium-free,
glutamine-free DMEM (Gibco) and Ham’s F-12 (Gibco) þ 0.2
ng/ml EGF þ 25 lg/ml BPE þ 1.5 mM L-glutamine þ pen/strep.
The primary human tracheobronchial epithelial cell line
TrBEp-1 (obtained from Cambrex, Walkersville, MD, http://
www.cambrex.com) and its derivatives were cultured in BEGM
medium (Cambrex). R2F primary human ﬁbroblasts and LP9 pri-
mary human mesothelial cells were grown in serum- and mito-
gen-supplemented media as described [20, 23].
To compare growth in different media, 9 cm
2 wells were
plated with 2,000 cells, grown for 7–9 days with refeeding every
2 days, and then trypsinized and counted. Growth rates were
calculated as log2(no. cells counted/no. cells plated)/no. days ¼
PD/day.
For replicative lifespan determination, cells were plated at
10
4 to 10
5 cells/p60 or p100 dish, refed every 2–3 days, and sub-
cultured 5–9 days after plating before growth was slowed by den-
sity. PD was calculated as log2(no. cells at subculture/no. cells
plated). Cumulative PD was plotted against total time in culture
to determine onset of senescence or immortalization [20, 23].
Organotypic Culture
Organotypic cultures were prepared as described [12, 13, 23].
Foreskin ﬁbroblasts (3   10
5) suspended in 3 ml of bovine colla-
gen I (1.1 mg/ml) (Organogenesis, Canton, MA, www.
organogenesis.com) were allowed to gel over a 1 ml layer of
acellular collagen in six-well culture inserts with 3-lm pore poly-
carbonate ﬁlters (Corning Life Sciences, Lowell, MA, http://
www.corning.com/lifesciences). Gels were allowed to contract for
4–5 days before seeding with 2.5   10
5 epithelial cells in serum-
and mitogen-supplemented DMEM/F12 raft medium [12, 13, 23].
Inserts were raised to the air-liquid interface 4 days later and
refed every 3 days for an additional 10 days. Membranes with
organotypic cultures were ﬁxed in 10% formalin, parafﬁn-embed-
ded, cut as 5-lm sections, and immunostained. Two experiments
conducted at different times with each cell line yielded organo-
typic cultures with similar morphologies. Measurements at 10
points across the central  5 mm cross section of each organo-
typic culture yielded SEM values  8% for thickness and numbers
of total and stratum corneum cell layers.
Retroviral Vectors and Transduction
BABE-bmi1.puro, Wzl-TERT.Bsd, and L(E6E7)SN vector plas-
mids were transfected into Phoenix or PA317 cells to produce
amphotropic packaging cells, which were incubated for 8 hours
in 1:1 medium 2–4 days after transfection to obtain retroviral
supernatants. As described [13, 20], epithelial cells plated 1–
2 days earlier at  10
5 cells per 9 cm
2 well were transduced for
 6 hours with retroviral supernatant þ2 lg/ml polybrene (Sigma-
Aldrich, St. Louis, http://www.sigmaaldrich.com). Transduced
cells were subcultured the next day into p100 dishes with K-sfm
medium, or p60 dishes with feeder cells and FAD medium. Drug
selection (0.5 lg/ml puromycin, 5 lg/ml blasticidin, or 0.2 mg/ml
G418) began 1 day after transduction and continued for 5–7 days.
Some transductants were made by coplating cells with c-irradi-
ated retroviral producer cells in FAD medium. Producer cells
were selectively removed 3–4 days later by brief incubation with
trypsin/EDTA and vigorous pipetting and irradiated, drug-resist-
ant 3T3J2 cells þdrug were added back to cultures.
Antibodies
Murine monoclonal antibodies (MuMoAb) used were as follows:
p16
INK4A (G175-405 [BD Pharmingen, San Diego, CA, http://
www.bdbiosciences.com/index[lowen]us.shtml]); Laminin c2
chain (D4B5 [Chemicon, Temecula, CA, http://www.chemicon.
com]); bmi1 (clone F6 [Millipore, Billerica, MA, http://www.
millipore.com]); involucrin (SY5 [Research Diagnostics, Flanders,
NJ, http://www.researchd.com]); K14 (CKB1 [Sigma-Aldrich]);
p63 (4A4 [provided by F. McKeon, Harvard Medical School]); and
K10 (AE20) and K5 (AE14) (provided by T.T. Sun, N.Y.U.
Medical School).
Immunocytochemistry and Immunohistochemistry
Cultured cells were ﬁxed and permeabilized in 100% cold metha-
nol, or ﬁxed in fresh 4% paraformaldehyde and permeabilized with
Triton X-100, and immunostained using avidin-biotin-complex
(ABC) peroxidase and NovaRed substrate (Vectastain Elite ABC,
Vector Laboratories, Burlingame, CA, http://www.vectorlabs.com),
as described [30, 31]. Five-micrometer parafﬁn sections of organo-
typic cultures were immunostained the same way. Antigen re-
trieval, by microwaving slides submerged in citrate buffer (pH 6),
was used before immunostaining sections for p63. Images were
captured on a NIKON E600 Microscope with a SPOT2 digital cam-
era using SPOTcam v.3.5.5 software (Digital Instruments, Tono-
wanda, NY, http://www.digitalinstruments.com).
Hypermotility Assays
Transforming growth factor beta (TGFb)- and Lam-3320-induced
hypermotility was visualized and quantitated as described [30]. Con-
ditioned medium (CM) from the rat bladder carcinoma cell line 804G
[53] was used as a source of c2 chain-unprocessed Laminin-332
(Lam-3320) [30, 54]. 804G cells were grown to conﬂuence in DMEM
þ 10% calf serum, refed with fresh medium, and returned to the incu-
bator for 8–16 hours. The CM was 0.2-lm ﬁlter sterilized (Nalge/
Nunc, Rochester, NY, http://www.nalgenunc.com) and stored at
 20 C. Wells (9 cm
2; Corning Life Sciences) were precoated by
incubating with 804G CM diluted one-third with 10% serum DMEM
for 30 minutes at 37 C and rinsed 3  with phosphate-buffered saline
(PBS) and once with K-sfm before plating cells in K-sfm. For some
experiments, cells were plated on untreated dishes in K-sfm þ0.3 ng/
ml recombinant human TGFb1 (R&D Systems, Minneapolis, MN,
http://www.rndsystems.com), added from a 1,000  concentrated
solution in 4 mM HCl þ0.1% BSA.
To measure directional hypermotility, wells plated with 700
cells were ﬁxed 1 day after plating on Lam-3320-precoated dishes,
or 2 days after plating in 0.1 mM Ca
2þ K-sfm þTGFb, in 10%
formalin/PBS for 30 minutes and immunostained as described
earlier with Laminin c2 MuMoAb D4B5 (Chemicon). Fifteen to
20 ﬁelds were photographed using a 2  objective. Laminin-332
pads and tracks deposited by >100 cells were scored for length
and width, as described [30]. Cells that deposited Laminin-332
tracks with <4:1 asymmetry were classiﬁed as nonmotile, with
tracks of 4:1-10:1 asymmetry and <500 lm in length as slightly
motile, and with tracks >500 lm in length as hypermotile.
Western Blotting
Proliferating cultures were trypsinized, PBS-rinsed, lysed in
20 mM Tris buffer (pH 7.3) þ2% SDS þprotease inhibitor cocktail
(Roche Diagnostics, Indianapolis, IN, http://www.roche-applied-
science.com) and sonically disrupted. Thirty micrograms (Bio-Rad
assay) of extract protein was separated by SDS-PAGE under
reducing conditions in precast, 4%–20% gradient gels (Bio-Rad,
Hercules, CA, http://www.bio-rad.com), electrotransferred to
PVDF membranes (Millipore), and speciﬁc proteins detected by
incubation with primary antibodies, peroxidase-conjugated
secondary antibody (Southern Biotech, Birmingham, AL), and
ECL chemiluminescence reagent (Amersham, Buckinghamshire,
UK, http://www.amersham.com). Membranes were stripped of
antibody using BlotFresh (SignaGen Labs, Gaithersburg, MD,
1390 Human Stem Cell-Derived, p63
þ Epithelial Cellshttp://www.signagen.com) and reprobed with b-actin antibody (A-
2066; Sigma) as loading control.
RESULTS
The Replicative Potential of hESderK Cells Is
Limited by a p16
INK4A-Enforced
Senescence Mechanism
As reported previously, the p63
þ/K14
þ (hESderK) cell popu-
lation recovered from H9 hES teratomas by cultivation in
semideﬁned keratinocyte media or with 3T3 feeder support
could not be propagated beyond 10–15 PD [35, 37]. On the
basis of our experience with normal primary human keratino-
cytes [20], we hypothesized that hESderK cells were senesc-
ing from p16
INK4A induction. In their ﬁnal passage, all large,
nondividing hESderK cells proved to be p16
þ (Fig. 1A). After
E6E7-transduction, hESderK cells divided rapidly and
indeﬁnitely (Fig. 1C) despite p16 expression (Fig. 1B), as was
also the case for E6E7-transduced epidermal keratinocytes
(Fig. 1E). This was expected, considering that E7 inactivates
retinoblastoma protein and renders cells indifferent to p16
expression. The E6E7 transductants grew as immortalized
lines, as expected since, in addition to inactivating p53 to
render cells indifferent to p14
ARF expression, E6 facilitates
derepression of the endogenous TERT gene [55].
p16-deﬁcient variants can arise in TERT-transduced, pri-
mary keratinocyte cell lines that have a long lifespan, such as
strain N, and these variants prevail as the observed immortal-
ized lines [20, 24, 25]. However, primary keratinocyte lines
with short lifespans may not generate such variants following
TERT transduction before all cells in the population have
induced p16 and senesced (Fig. 1D). As an alternative to E6E7
expression, we transduced early passage hESderK cells to
express bmi1, a polycomb protein that in early passage cells
maintains the p16
INK4A/p14
ARF locus transcriptionally inactive
Figure 1. Extending the replicative lifespan of hES-derived epithelial cells by evading the p16
INK4A senescence mechanism. (A): p16 immuno-
cytochemical staining of hESderK cells in their third and ﬁnal passage before senescence, growing in Gibco K-sfm medium (phase contrast left;
bright-ﬁeld, right). Note that small proliferative, colony-forming cells are p16-negative and large, nondividing cells are p16-positive. The large,
very ﬂat cells, p16-negative in these ﬁelds are irradiated 3T3 ﬁbroblast feeder cells that had been carried over from the previous passage. Bar in
top left panel is 200 lm long. (B): Western blot analysis of bmi1 and p16 expression. Lanes: (1) early passage strain N epidermal keratinocyte;
(2) late passage N/bmi1; (3) hESderK/bmi1; (4) hESderK/E6E7 clone K; (5) late passage HBl-10U; (6) late passage HBL-10U/bmi1. Note that
constitutive bmi1 expression is associated with reduced p16 expression in normal keratinocytes, hESderK cells, and normal urothelial cells and
that hESderK/E6E7 cells express high levels of p16 but are still able to proliferate, consistent with Rb-inactivation by E7. (C–E): Replicative
lifespans of primary cell lines and engineered derivatives; arrows indicate timing of transductions during serial passage of this line; asterisks indi-
cate the normal replicative lifespan limit (senescence) of the primary cell line. (C): Lifespan extension and immortalization of hESderK cells.
Note that hESderK cells senesced by 10 population doublings (PD) and were not immortalized by TERT. Expression of bmi1 in the parent line
conferred a long extension of lifespan to  60 PD. Transduction of the parent line to express E6 and E7 resulted in immortalization and also a
substantial increase in growth rate to the  1 PD/day rate exhibited by early passage normal keratinocytes and their engineered derivatives. (D):
Lifespan extension and immortalization of normal primary corneal keratinocyte line KL5. Note that KL5 had a very short lifespan of  23 PD,
which was not altered by TERT expression. Transduction of KL5 to express bmi1 resulted in extension of lifespan to  37 PD and subsequent
transduction of KL5/bmi1 cells to express TERT resulted in immortalization. (E): Lifespan extension and immortalization of normal primary
human epidermal keratinocyte strain N. Note that transduction of strain N to express bmi1 resulted in extension of replicative lifespan from 70 to
90 PD, and subsequent transduction of N/bmi1 to express TERT resulted in immortalization. Transduction of strain N to express HPV16E6 and
E7 also resulted in immortalization. Abbreviations: TERT, telomerase catalytic subunit.
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extended the lifespan of normal keratinocytes (Fig. 1D, 1E), as
expected from a previous study [49]. hESderK/bmi1 transduc-
tants also displayed a greatly extended lifespan (Fig. 1C), asso-
ciated with repression of p16 (Fig. 1B). Constitutive bmi1
expression was not sufﬁcient to immortalize keratinocytes, but
bmi1 transductants became immortalized when subsequently
transduced to express TERT (Fig. 1C–1E). For unknown
reasons, we have been unable to obtain a TERT-immortalized
version of hESderK/bmi1, but hESderK/bmi1 has such a long
lifespan that it could be studied in detail. We concluded that
hESderK cells, like keratinocytes, possess an active p16-senes-
cence mechanism that is much more readily activated in culture
than it is in normal keratinocytes, but which can be evaded
experimentally by E6E7 or bmi1 expression.
Early passage normal, bmi1-transduced, and E6E7-trans-
duced keratinocytes grew rapidly, at a rate of nearly one PD
per day. hESderK/E6E7 cells grew nearly this rapidly but
hESderK/bmi1 grew more slowly, at  0.4 PD/day. When
hESderK/bmi1 cells were transduced to express E6E7, they
began proliferating at  1 PD/day and became immortalized.
We concluded that the feeder/FAD culture system is permis-
sive for hESderK cells but is not as optimal for their growth
as it is for normal keratinocytes [21, 52]. Because E6E7
expression permitted hESderK cells to divide more rapidly in
the feeder/FAD system, we further concluded that E6E7
expression permits hESderK cells to bypass a requirement for
a mitogen or other factor not present in the feeder/FAD sys-
tem or not at optimal concentrations for hESderK cells.
Colony Morphology, Growth Requirements, and
Marker Expression of hESderK Clones
We compared hESderK/bmi1 and two clonally derived hES-
derK/E6E7 lines to normal and engineered epidermal kerati-
nocytes. All formed colonies from single cells were serially
cultivable in the ﬁbroblast feeder/FAD system. hEsderK/E6E7
clone 2, reported previously [35], and hESderK/bmi1 both
formed loosely associated, nonstratifying colonies. We iso-
lated clone K from the initial, uncloned hESderK/E6E7-trans-
duced population for its close-packed colony morphology
resembling that of normal and E6E7- or bmi1/TERT-trans-
duced epidermal keratinocytes (Fig. 2A).
We tested the hESderK lines for their ability to grow in
several culture media permissive or nonpermissive for normal
keratinocytes. Normal primary and E6E7 or bmi1þTERT
transduced epidermal keratinocytes all grew well in K-sfm or
in the feeder/FAD system, but could not grow in FAD me-
dium without feeder cells (Fig. 2B). All three hESderK lines
grew best in the feeder/FAD system and cl2 and clK were
also able to grow in K-sfm. Notably, in contrast to normal
and experimentally immortalized keratinocytes, the cl2 and
clK could grow progressively in FAD medium without feeder
cells, although more slowly than in the presence of feeder
cells, and in medium lacking EGF. hESderK/bmi1, which
grew slowly even in the feeder/FAD system, could not be
propagated in K-sfm (Fig. 2B).
Western blots (Fig. 2C) of cells cultured to conﬂuence in
K-sfm medium disclosed that the engineered versions of hES-
derK cells and keratinocytes retained expression of p63 and
involucrin. Immunohistochemical staining of preconﬂuent cul-
tures of cells plated at low density in K-sfm permitted evalua-
tion of individual cells in growing colonies for expression of
these and other proteins that are expressed by normal kerati-
nocytes. hESderK cells grown in K-sfm medium expressed
K14 and the basement membrane protein Laminin-332, the
latter revealed by immunostaining to be secreted onto the cul-
ture dish (Fig. 2D).
hESderK Cells Display Hypermotility Responses to
the Same Stimuli as Normal Keratinocytes
Our lab recently reported that normal epidermal and oral ke-
ratinocytes respond with sustained, directional hypermotility
when treated with TGFb or when plated on the c2 chain
unprocessed form of Laminin-332 (Lam3320) [30]. As
revealed by tracks of Laminin-332 on the culture dish, hES-
derK cells also responded to TGFb and Lam3320 with direc-
tional hypermotility (Fig. 3A). hESderK/bmi1 exhibited this
response more weakly to both stimuli and hESderK/E6E7 cl
K showed a somewhat reduced response to TGFb compared
with normal primary keratinocytes and their E6E7-engineered
derivatives (Fig. 3B).
We concluded from all the above experiments that expres-
sion of E6E7, bmi1, or bmi1þTERT did not substantially alter
the morphology, growth, or marker protein expression of nor-
mal somatic keratinocytes. Therefore, the morphologic and
growth requirement differences between hESderK cells and
normal keratinocytes cannot be attributed to the methods used
to extend lifespan or immortalize them. Despite these differen-
ces, the expression of p63, K14, involucrin, and Laminin-332
by hESderK cells and their possession of the p16
INK4A senes-
cence mechanism and the hypermotility response was consist-
ent with an identity as keratinocyte.
Histogenic Potential of hESderK Cells
We next compared the tissue-forming ability of hESderK cells
to that of epidermal keratinocytes in organotypic culture. In
these conditions, normal and E6E7-engineered keratinocytes
and hESderK/E6E7 clone K cells formed stratiﬁed epithelia
with a normal pattern of p63 expression (Fig. 4A). Neither
E6E7 nor bmi1 expression prevented normal epidermal kerati-
nocytes from generating a ﬂattened, eosinophilic, stratum
corneum-like upper layer (Fig. 4A, 4B). Strain N and its engi-
neered derivatives also expressed involucrin and the epider-
mal differentiation protein K10 in suprabasal cells, although
N/E6E7 expressed K10 only sporadically.
The three hESderK lines all formed multilayered epithelia
that differed morphologically, by absence of a stratum cor-
neum-like layer, from the epithelia formed by strain N and its
derivatives and by the  20 wk fetal epidermal keratinocyte
line J4Ep. hESderK/E6E7 clK formed the thickest epithelium
(even thicker than that formed by strain N or N/E6E7) and
hESderK/bmi1 the thinnest, but the morphologic structures
formed by the three hESderK lines were similar (Fig. 4B).
hESderK/E6E7 cl2 and clK expressed suprabasal involucrin
in abundance and clK also expressed K10 in many suprabasal
cells. hESderK/bmi1 expressed involucrin and K10 only in
rare suprabasal cells. Thus, hESderK cells have some tissue-
forming and terminal differentiation characteristics of normal
epidermal keratinocytes in organotypic culture, namely, strati-
ﬁcation and p63, involucrin, and K10 expression; yet, they
differed from postnatal and from  20 week fetal keratino-
cytes by a lack of stratum corneum formation.
Properties of Other p63
1 Cell Types Cultured from
Normal Human Epithelial Tissues
A number of epithelial cell types other than keratinocytes
express p63 [41]. We examined the properties in culture of
two of these: urothelial and tracheobronchial epithelial cells.
Previous studies revealed that primary human urothelial cells
grow well in the feeder/FAD system and maintain a distinc-
tive pattern of cytokeratin protein expression [19, 50, 51].
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cheobronchial cells grew well in the FAD/feeder system and
formed closely packed colonies with morphologies slightly
different from that of keratinocytes, in that the cells were less
regular in shape and were more oval and elongated than kera-
tinocytes (Figs. 2A and 5A). HBl-10U grew as well as kerati-
nocytes in K-sfm (Figs. 2B and 5A) but TrBEp-1 did not
(data not shown), although it did grow well in BEGM, a pro-
prietary, BPE-supplemented medium designed for tracheo-
bronchial cells (Fig. 5A). Urothelial and tracheobronchial epi-
thelial cells shared with keratinocytes and hESderK cells
expression of p63, p16, and Laminin-332, and hypermotility
in response to TGFb and Lam-3320 (Figs. 4B and 2D; data
not shown). Both cell types proved to be subject to p16
INK4A/
p14
ARF-enforced senescence, such that TERT transduction did
not result in immortalization but transduction to express bmi1
Figure 2. Morphology, growth, and marker expression of hESderK cells in conventional culture. (A): Colony morphologies in the feeder/FAD sys-
tem. Shown are typical colonies formed by single cells of each line during serial passage. Note closely packed morphology with clearly demarcated
cell-cell borders in colonies formed by strain N, N/E6E7, N/bmi1/TERT, and hESderK/E6E7 clone K, in contrast to the more rounded, refractile, irreg-
ular, and fragmented colony morphology of hESderK/E6E7 clone two and hESderK/bmi1. Bar in top left panel is 200 lml o n g .(B): Distinctive growth
requirements displayed by hESderK cells. Data are the average of three experiments, with error bars showing standard error of the mean. Asterisks indi-
cate conditions in which cells did not grow beyond their plating density. Note ability of the hESderK lines to grow in FAD medium without feeder
ﬁbroblasts, the absence of a stringent EGF requirement for cl2 and clK, and the poor growth of hESderK/bmi1 cells in K-sfm. Growth requirements of
normal keratinocytes were unaltered by transduction to express E6E7 or bmi1þTERT. Urothelial cells (HBl-10U) displayed the same growth require-
ments as keratinocytes. (C): Western blot analysis of p63 and involucrin expression. Lanes: (1) hESderK/bmi1; (2) hESderK/E6E7 cl K; (3) hESderK/
E6E7 cl 2; (4) N/E6E7; (5) strain N keratinocyte; (6) LP9 mesothelial cell; (7) R2F ﬁbroblast. Note p63 expression by engineered hESderK and kerati-
nocytes. Note continued expression of involucrin, albeit at reduced levels compared with normal keratinocytes, by the engineered cell lines, which cor-
related with relative frequencies of stratiﬁed cells in cultures of the various epithelial cell lines. (D): Immunocytochemical analysis of K14 and
Laminin-332 expression by hESderK cells. Cells plated at low density and grown for 5 days in K-sfm medium were ﬁxed in cold methanol and immu-
noperoxidase-stained for K14 and Laminin-332, revealing expression of these proteins at levels similar to that of normal epidermal keratinocytes and
the deposition of secreted Laminin-332 on the culture dish surface. Bar in top left panel is 200 lm long. Abbreviations: EGF, epidermal growth factor;
K-sfm, keratinocyte serum-free medium; PD, population doublings; TERT, telomerase catalytic subunit.
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sion, and made cells permissive for TERT immortalization
(Fig. 5C, 5D).
We tested the normal primary somatic epithelial cell types
and some of their bmi1 extended lifespan and bmi1þTERT
immortalized derivatives for p63 and K5 expression (note that
K5 is the partner of K14 for cytokeratin ﬁlament formation),
comparing cultures grown to near conﬂuence in the same
feeder/FAD conditions to avoid the possibility that different
culture medium formulations would inﬂuence protein expres-
sion. All cell types and their engineered versions retained
expression of these markers (Fig. 6A). Urothelial and tracheo-
bronchial epithelial cells both expressed involucrin in culture
(Fig. 6A) which, considering their behavior in vivo, was
expected for urothelial [56] but unexpected for tracheobron-
chial cells [57].
Histogenic Potential of p63
1 Epithelial Cell Types in
Organotypic Culture Conditions
Finally, we examined the histogenic potential of urothelial
and tracheobronchial cells (Fig. 6B). Both cell types formed
multilayered epithelia with most suprabasal cells expressing
involucrin, similar to normal keratinocytes and hESderK cells.
K10 was expressed by most suprabasal urothelial cells but
was sporadic in tracheobronchial cultures. Surprisingly, both
cell types formed a thin, ﬂattened, eosinophilic stratum cor-
neum-like layer, unlike the tissue they normally form in vivo.
Increasing the retinoic acid concentration in the medium did
not suppress this (data not shown). We concluded from these
experiments that p63
þ epithelial cell types other than kerati-
nocytes can activate expression of involucrin during growth
in conventional culture, even in conditions that promote rapid
proliferation, and that they can display a squamous metaplas-
tic, keratinized form of differentiation in standard organotypic
culture conditions, which had been optimized originally for
epidermal keratinocyte histogenesis. This precluded conclu-
sive identiﬁcation of hESderK cells as a keratinocyte or any
speciﬁc somatic epithelial cell type.
DISCUSSION
Our objective was to identify the p63
þ/K14
þ cells that can
arise from hES cells. We and others [33–37] had concluded
Figure 3. Induction of directional hyper-
motility in hESderK cells and normal kera-
tinocytes. (A): Directional hypermotility,
revealed by immunostaining for Laminin-
332, comparing cells 2 days after plating in
control conditions, with 0.3 ng/ml TGFb,
and plating on dishes precoated with the c2
unprocessed form of Laminin-332
(Lam3320). Note the similar, robust motility
responses of all cell lines except for hES-
derK/bmi1, which was responsive but
weaker than the other lines. (B): Quantita-
tion of hypermotility responses. Note that a
smaller percentage of hESderK/bmi1 cells
responded to TGFb and Lam3320 with
hypermotility than did normal epidermal
keratinocytes, N/E6E7, and hESderK/E6E7
clone K cells and that normal primary
TrBEp-1 were very responsive. Data are
the average of three experiments, with error
bars showing standard error of the mean.
Abbreviations: TGFb, transforming growth
factor beta; TERT, telomerase catalytic
subunit.
1394 Human Stem Cell-Derived, p63
þ Epithelial Cellspreliminarily that these ‘‘hESderK’’ cells are keratinocytes.
Our extensive analysis and comparison with three structurally
and developmentally different p63þ epithelial cell types has
disclosed that this identiﬁcation was incorrect. hESderK cells
share with keratinocytes, urothelial cells, and tracheobronchial
epithelial cells a set of hypermotility, marker expression, and
histogenic characteristics in culture. However, hESderK cells
differ from these normal somatic cell types by having less
stringent growth requirements, extremely limited replicative
potential, and a different tissue architecture in organotypic
conditions.
The very limited replicative potential of hESderK cells
proved to be the consequence of a p16
INK4A/p14
ARF senes-
cence mechanism, apparently identical to that of normal kera-
tinocytes and other p63
þ epithelial cell types but subject to
induction sooner during serial culture than it is in normal epi-
thelial cells. hESderK cells resembled a short lifespan primary
keratinocyte line and the primary urothelial and tracheobron-
chial epithelial cell lines studied here, in that they were not
immortalized by TERT expression alone. Transduction to
express bmi1, which maintains the normal, repressed state of
the p16
INK4A/p14
ARF locus [47–49], greatly extended the life-
span of hESderK cells without changing morphology, growth
requirements, or differentiation characteristics. As previously
reported for keratinocytes [49], but unlike a result reported
for a mammary epithelial cell line [47], bmi1 expression in
the epithelial cell types that we studied did not facilitate dere-
pression of endogenous TERT to yield immortalized lines but,
instead, made cells permissive for TERT immortalization. An
advantage of using bmi1þTERT to immortalize epithelial
cells is that, unlike E6E7 expression, or the coexpression of
dominant-negative mutant p53, p16-resistant mutant cdk4, and
TERT that we used previously [23], p53- and pRB-dependent
controls remain intact. In situations in which an immortalized
line eventually emerges following transduction of keratino-
cytes to express TERT alone, such lines prove to be variants
Figure 4. Histogenesis and differentia-
tion-related protein expression by epider-
mal keratinocyte and hESderK cells in
organotypic culture conditions. (A): Histo-
genesis and p63 expression (left frame he-
matoxylin and eosin-stained, right frame
p63 immunostain with light hematoxylin
counterstain), comparing foreskin tissue
with organotypic cultures of strain N epi-
dermal keratinocytes, N/E6E7, and hES-
derK/E6E7 clone K. Bar in top left panel is
100 lm long. (B): Histogenesis and involu-
crin and K10 expression. Panels show typi-
cal ﬁelds. Average total epithelial thickness
in lm, number of cell layers, and number
of stratum corneum cell layers were as fol-
lows: for foreskin epidermal tissue (100
lm, 8, 3); organotypic cultures of strain N
(60 lm, 5, 2); N/E6E7 (75 lm, 5, 4); N/
bmi1 (70 lm, 4, 2); hESderK/E6E7 clone
K (140 lm, 10, 0); hESderK/E6E7 clone 2
(75 lm, 5, 0); hESderK/bmi1 (50 lm, 4,
0), and J4Ep (50 lm, 3, 5). Note p63
expression pattern in organotypic cultures
similar to that of epidermal tissue in vivo.
Note suprabasal expression of involucrin in
suprabasal cells of all cell lines tested
except for only sporadic expression in hES-
derK/bmi1 cells, and K10 expression by
many suprabasal cells of strain N, N/bmi1,
hESderK/E6E7 clone K, and J4Ep but only
sporadic expression by N/E6E7, hESderk/
E6E7 clone 2, and hESderK/bmi1. Bar in
top left panel is 100 lm long.
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in loss of or reduced p16/p14
ARF expression [23–25].
Bmi1þTERT expression are well-deﬁned events that obviate
selection pressure for mutants. Furthermore, since bmi1 is
normally expressed by early passage keratinocytes and other
cell types, maintaining expression at levels similar to that of
early passage cells should not result in abnormal repression of
other genes.
The mechanism triggering p16 expression and senescence
appears to be much more sensitive to activation in hESderK
cells than in normal somatic p63
þ epithelial cells. p16 is nei-
ther expressed in normal epithelial tissues nor is necessary for
their development [28, 29, 31] but is expressed in the epider-
mis and oral epithelium in vivo in the settings of wound re-
epithelialization and neoplastic progression toward squamous
cell carcinoma (SCC) [30, 31]. In the latter setting, p16
expression serves as an important tumor suppressor against
the formation of SCC. During human development, the deﬁni-
tive epidermis and other stratiﬁed squamous epithelia do not
form until  20 weeks gestation. Complete maturation of
mechanisms regulating CDKN2A, ﬁne-tuning it for normal
repression and ability to be activated in appropriate circum-
stances, may not occur during the several week period in
which hESderK cells form from hES cells in the experimental
settings used to date. hESderK cells also do not have the
same growth requirements as normal p63
þ epithelial cells.
Unless assisted by E6E7 expression, they did not grow as rap-
idly as normal p63þ cell types in the feeder/FAD or K-sfm
Figure 5. Characteristics of two nonkeratinocyte, p63þ human epithelial cell types in culture. (A): Colony morphologies in the feeder/FAD sys-
tem and in semideﬁned media. Note that urothelial cells (HBl-10U) and TrBEp-1 form tightly packed colonies in the feeder/FAD system, but cell
shapes are slightly different (less regular and more elongated) from that of keratinocytes (shown in Fig. 2A). Urothelial cells and tracheobronchial
epithelial cells form colonies that are less cohesive than that of keratinocytes but more cohesive than that of hESderK cells in semideﬁned me-
dium. (TrBEp-1 did not grow well in K-sfm, so was cultured in BEGM, as described in Methods.) Bar in top left panel is 200 lm long. (B):
Marker expression and directional hypermotility response of urothelial cells. HBl-10U cells expressed p63 in all cells, p16
INK4A in large, nondi-
viding cells, and Laminin-332, which disclosed their directional hypermotility response to TGFb and to plating on Lam-3320. Bar in left panel is
200 lm long. (C, D): Immortalization of HBl-10U urothelial cells (c) and TrBEp-1 tracheobronchial epithelial cells (d), by engineering to evade
the p16-senescence mechanism and to express TERT. Note that TERT expression was insufﬁcient to immortalize TrBEp-1 cells, whereas bmi1
expression conferred extended lifespan and ability to become immortalized by subsequent transduction to express TERT. HBl-10U responded
similarly to bmi1 and bmi1þTERT expression and was immortalized by E6E7. Arrows and asterisks as in Figure 2. Abbreviations: K-sfm, kerati-
nocyte serum-free medium; TGFb, transforming growth factor beta; TERT, telomerase catalytic subunit.
1396 Human Stem Cell-Derived, p63
þ Epithelial Cellssystems and hESderK cells could to grow in serum-supple-
mented medium without ﬁbroblast feeder cell support and
without EGF. They neither form extensive cell-cell junctions
nor did stratify in colony centers during growth in the feeder/
FAD system, as do normal p63
þ cell types. This suggests that
p63
þ cells derived experimentally from hES cells either did
not have the time or did not have the proper environment to
fully develop the growth and differentiation regulatory mecha-
nisms of normal somatic epithelial cells.
Research on p63 has focused on its role in epidermal de-
velopment, differentiation, and proliferative potential [38, 39,
42, 58] but many other epithelia express p63, and this protein
is essential for their development (for example, see refs [41,
59, 60].). An earlier study [19] showed that several nonkerati-
nocyte epithelial cell types, including urothelial cells, form
colonies from single cells, divide rapidly, and can be serially
passaged in the feeder/FAD system. Normal tracheobronchial
epithelial cells proved here to grow well in this system as
well. As reported previously for keratinocytes [20], primary
lines of these other cell types grew well in semideﬁned
media, with urothelial cells growing optimally in K-sfm and
tracheobronchial epithelial cells in BEGM. The expression of
Laminin-332 by hESderK cells and the induction of direc-
tional hypermotility by TGFb or the c2 chain precursor form
of Laminin-332 [30, 31] at ﬁrst seemed to support their iden-
tity as keratinocyte. Our ﬁnding that urothelial cells and tra-
cheobronchial epithelial cells also display this response, to-
gether with the results of a separate study of human prostate
epithelial cells (Wei and Rheinwald, in preparation) now per-
mits us to generalize this as a response of all p63
þ, Laminin-
332
þ cell types.
The morphology, growth requirements, and differentiation
characteristics of urothelial and tracheobronchial epithelial
cells in culture more closely resembled those of keratinocytes
than of hESderK cells. We were most surprised by the similar
histogenic behavior and involucrin and K10 expression of all
these cell types in organotypic culture. Our results showed
that p63
þ epithelial cell types of endodermal origin, which
normally either do not stratify or do not become corniﬁed in
vivo, express in culture the stratiﬁed squamous epithelial cor-
niﬁed envelope protein involucrin and the epidermoid differ-
entiation-related keratin ﬁlament protein K10. The organo-
typic culture system widely used to evaluate epithelial
differentiation was originally optimized to yield a well-differ-
entiated epidermis from cultured epidermal keratinocytes [11,
12]. We found previously that this system results in more epi-
dermal-like suprabasal differentiation by nonepidermal kerati-
nocyte subtypes than those subtypes display in vivo [13].
Involucrin expression and stratiﬁed, epidermoid differentiation
exhibited by tracheobronchial epithelial cells, which form a
ciliated, pseudostratifed, involucrin-negative epithelium in
vivo [40], indicate that these cells express an abnormal, squa-
mous metaplastic, differentiation program in culture. Interest-
ingly, the propensity of many epithelial cell types to display
this behavior was ﬁrst detected for rat cells by their formation
of corniﬁed envelopes [61] in culture. Increasing the retinoic
acid concentration in the organotypic culture medium was
insufﬁcient to prevent this squamous metaplastic behavior in
our study and in a previous one [13]. Differences among nor-
mal epithelial cell types, even among different keratinocyte
subtypes (e.g., oral vs. epidermal), with respect to expression
of some marker cytokeratin proteins persist during growth in
conventional culture [9, 10, 13, 19, 51], but the tendency to-
ward epidermoid differentiation in organotypic culture com-
plicates the precise identiﬁcation of unknown epithelial cell
types such as hESderK cells.
Important future goals of this research are to characterize
p63
þ cell types arising from hES cells and improve culture
conditions to obtain completely developed, proliferative so-
matic epithelial cell types restricted to formation of a single
tissue. Previous studies have focused on the H9 and H1 hES
cell lines. It will be very important to examine the p63
þ dif-
ferentiation potential of other hES lines, because hES lines
vary with respect to their abilities to develop into various lin-
eages [62]. The hESderK cell lines we have isolated appear to
be an immature stage, or abnormal form, of p63
þ epithelial
development and it remains to be determined whether they
are on the pathway to ectodermal or endodermal lineages. Ex-
posure to certain types of fetal mesenchyme may provide spe-
ciﬁc direction and induce lineage maturation. The morphology
and some of the growth characteristics of the hESderK cells
are reminiscent of the XB2 murine teratoma-derived, kerati-
nocyte-like cell line, the discovery and early experimentation
of which [63] led to the ﬁrst serial cultivation of normal
human keratinocytes [21]. The hESderK/bmi1 line, able to
grow progressively but not rapidly in media now available,
should prove useful for optimzing media to culture and study
precursors and intermediate stages of epithelial development
as it occurs naturally or during somatic cell generation from
hES or induced pluripotent stem cells.
Figure 6. Differentiation-related protein expression in conventional culture and epithelial histogenesis in organotypic culture by urothelial and tra-
cheobronchial epithelial cells. (A): Western blot analysis. Urothelial cells and tracheobronchial epithelial cells were compared with epidermal kera-
tinocytes and hES-derived, keratinocyte-like (hESderK) cells for p63, K5, and involucrin expression during growth in the feeder/FAD culture
system (except for lane 2). Lanes: (1) strain N; (2) strain N grown in keratinocyte serum-free medium medium; (3) N/bmi1; (4) HBl-10U; (5) HBl-
10U/bmi1/TERT; (6) TrBEp-1/bmi1/TERT; (7) hESderK/bmi1. Note that p63 and K5 expression levels were highest for epidermal keratinocytes
and were positive, but lower, for the other cell types examined. Involucrin was expressed by all cell lines, but was highest in normal epidermal kera-
tinocytes and urothelial cells and at lower levels by bmi1 transductants of these cell types. The absence of stratiﬁcation in hESderK cells cultured
on plastic culture dishes likely contributed to the very low levels of this suprabasal differentiation-speciﬁc protein in hESderK/bmi1 cultures.
(B): Suprabasal differentiation protein expression in organotypic cultures of urothelial and tracheobronchial epithelial cells. Top row: HBl-10U/
bmi1/TERT. Bottom row: TrBEp-1. Panels show typical ﬁelds. Average total epithelial thickness in lm, number of cell layers, and number of stra-
tum corneum cell layers were as follows for HBl-10U/bmi1/TERT (90l, 6,1) and TrBEp-1 (70l, 6, 2). Note suprabasal expression of involucrin
and K10 in suprabasal cells of both cell types. Bar in top left panel is 100 lm long. Abbreviations: TERT, telomerase catalytic subunit.
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